Original Articles and Brief Reports

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow

MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich;Department for Stem Cell Transplantation, University of Hamburg, Germany
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
MLL Munich Leukemia Laboratory, Munich
Vol. 97 No. 10 (2012): October, 2012 https://doi.org/10.3324/haematol.2012.064683